Page last updated: 2024-10-28

miltefosine and Leukemia

miltefosine has been researched along with Leukemia in 5 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research Excerpts

ExcerptRelevanceReference
"D-19391 was added to the SK-BR-3 breast cancer cell line and HePC to the Molt-4 leukemia cell line in concentrations of, respectively, 18."1.30Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography. ( Brochez, V; De Potter, CR; Diniz, JA; Van den Eeckhout, EG; Van Heuverswyn, D, 1999)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berkovic, D3
Berkovic, K1
Fleer, EA3
Eibl, H2
Unger, C2
Goeckenjan, M1
Lüders, S1
Hiddemann, W2
Haase, D1
Brochez, V1
Van Heuverswyn, D1
Diniz, JA1
De Potter, CR1
Van den Eeckhout, EG1
Hochhuth, C1
Doenecke, D1

Other Studies

5 other studies available for miltefosine and Leukemia

ArticleYear
Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:4

    Topics: Antineoplastic Agents; Cell Division; Cell Membrane; Cytosol; Diglycerides; Dose-Response Relationsh

1994
Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells.
    Journal of experimental therapeutics & oncology, 1996, Volume: 1, Issue:5

    Topics: Antineoplastic Agents; Cell Membrane; Cells, Cultured; Chromatography, Thin Layer; Enzyme Activation

1996
Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
    Journal of experimental therapeutics & oncology, 1996, Volume: 1, Issue:6

    Topics: Antigens, Surface; Antineoplastic Agents; Cholesterol; Chromosomes; Drug Resistance, Neoplasm; Flow

1996
Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography.
    Lipids, 1999, Volume: 34, Issue:5

    Topics: Antineoplastic Agents; Breast Neoplasms; Chromatography, Gas; Humans; Leukemia; Phosphorylcholine; R

1999
Early effects of hexadecylphosphocholine on gene expression in leukemia cell lines.
    Progress in experimental tumor research, 1992, Volume: 34

    Topics: Antineoplastic Agents; Humans; Leukemia; Phosphorylcholine; Transcription, Genetic; Tumor Cells, Cul

1992